Piramal Finance Limited has announced the successful completion of its divestment from Shriram Life Insurance Company Limited, marking a significant milestone in the company's strategic portfolio management. The transaction involved the complete sale of its stake in the insurance entity for a total consideration of ₹600 crores to Sanlam Emerging Markets (Mauritius) Limited.

Transaction Details

The divestment process reached its conclusion following the receipt of all necessary regulatory clearances. According to the company's official filing with stock exchanges, the transaction funds of ₹600 crores were received on 30 March 2026, officially completing the sale process that was initially announced on 19 December 2025.

Regulatory Compliance

The company filed the completion intimation under Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Company Secretary Bipin Singh and submitted to both BSE Limited and National Stock Exchange of India Limited, ensuring full compliance with disclosure requirements.

Strategic Implications

This divestment represents a strategic move by Piramal Finance to optimize its investment portfolio and realize capital from its insurance sector holdings. The successful completion of the transaction, following regulatory approvals, demonstrates the company's ability to execute planned asset sales effectively.

The ₹600 crore proceeds from this transaction will likely strengthen Piramal Finance's capital position and provide additional resources for its core business operations and growth initiatives. The completion of this sale marks the end of Piramal Finance's investment in the life insurance sector through Shriram Life Insurance Company Limited.

Piramal Finance Limited has announced significant corporate developments following its board meeting held on March 27, 2026, including subsidiary amalgamation approval, substantial debt instrument authorization, and a key board resignation. The company has also provided formal intimation to stock exchanges regarding upcoming committee meetings for NCD considerations.

Scheme of Amalgamation Approved

The board has approved a comprehensive scheme of amalgamation involving Piramal Finance and three wholly-owned subsidiaries after considering the recommendation and report of the Audit Committee. The amalgamation includes Piramal Corporate Tower Private Limited, Piramal Agastya Offices Private Limited (formerly PRL Agastya Private Limited), and DHFL Investments Limited.

The scheme requires approval from the National Company Law Tribunal Mumbai Bench, Insurance Regulatory and Development Authority of India, shareholders and creditors as directed by NCLT, and other regulatory authorities. The proposed merger aims to simplify the group structure, optimize capital allocation, strengthen the balance sheet, and enhance operational and financial efficiency.

Rs. 15,000 Crore NCD Issuance Authorization

The board has sanctioned the issuance of redeemable non-convertible debentures on a private placement basis. The authorization covers NCDs worth up to Rs. 15,000 crore during April 1, 2026 to March 31, 2027, to be issued in one or more tranches as decided by the Committee of Directors.

Committee Meeting Intimation

Piramal Finance has formally notified both BSE and NSE under Regulations 29 & 50 of SEBI Listing Regulations about upcoming Committee of Directors meetings. The Committee of Directors (Administration, Authorisation & Finance) will convene from time to time during April 1, 2026 to March 31, 2027 to consider and approve the issuance and allotment of NCDs, subject to market conditions.

Board Composition Changes

Gautam Bhailal Doshi (DIN: 00004612) has resigned as Non-Executive Independent Director effective March 27, 2026, citing personal reasons. In his resignation letter, Doshi expressed gratitude for serving as an Independent Director of one of India's leading financial companies, describing it as a "privilege" and "humbling experience." He confirmed no other material reasons for his resignation beyond personal exigencies.

Doshi also holds directorships in other listed companies including Suzlon Energy Limited and Sun Pharmaceutical Industries Limited, where he serves in various committee positions.

Business Operations Overview

Piramal Finance operates as a Non-Banking Financial Company registered with the Reserve Bank of India, focusing on retail lending, corporate mid-market lending, and real estate developer lending. The subsidiaries being amalgamated operate in complementary areas including real estate services, property development, and investment activities.

Regulatory Compliance

All announcements comply with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, under Regulations 30 and 51. The scheme will be filed with stock exchanges as per Regulation 37 requirements and SEBI Master Circular provisions. The official documentation was signed by Company Secretary Bipin Singh, with the complete details available on the company website at www.piramalfinance.com .